In December 2013, Cancer52 wrote a letter to Sir John Chisholm, Executive Chair of Genomics England, expressing its alarm that the 100K...

Cancer52 had a stand at exhibition at the MacMillan Primary Care Conference in November 2013. Visitors to the stand learned of the work...

The government agreed to full consultation of the Medical Innovation Bill spearheaded by Lord Saatchi. Jeremy Hunt, the Secretary of...

A new report from the National Cancer Research Institute (NCRI) and Cancer52 was published in November 2013, showing for the first time...

Cancer52's Third Annual Briefing was held in October 2013 at the House of Lords. To read a summary debrief of the event please click here.

On 20th September 2013, Cancer52 published Briefing Papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF); alongside an...

Allyson founded Ovarian Cancer Action in 2004, as a campaigning voice for women with ovarian cancer - lobbying for greater understanding...

Rare and less common cancers are going up the media agenda - in June 2013 there was a massive piece in the Telegraph on neuro endocrine...

Cancer52 supported the CML Support Group's call for an apology from BBC Scotland for footage within its programme "Life, Death and...

On 13th November 2012, Cancer52 published its Position Statement on Value Based Pricing.